The board of directors at Be Bio has a history of experience with founding CEOs, Rectify Pharma, Lassen Therapeutics, Pyxis Oncology, Longwood Fund, Dyne Therapeutics, Generation Bio, and Disarm Therapeutics. All members have a degree from either Cornell University, The University of Chicago Booth School of Business, or Yale University in biology, strategy, finance, or history.
View all